You are here

JPMHC 2024

Why selling to Novartis made sense for Mariana

BioPharma Dive

Sun, 05/5/24 - 11:37 pm

JPM2024: Lilly CEO David Ricks Weighs In on GLP-1s and AI

BioSpace

Mon, 01/15/24 - 09:43 am

artificial intelligence

JPM2024: IRA Favors Biologics Over Small Molecule Drugs and Hurts Innovation, Industry Analysts Say

BioSpace

Fri, 01/12/24 - 11:36 am

Inflation Reduction Act

small molecule drugs

7 JPM Announcements You Don’t Want to Miss

MedCity News

Fri, 01/12/24 - 09:51 am

Boston Scientfic

artificial intelligence

JPM2024: Cancer Biotech Executives Look Ahead to the Coming Year

BioSpace

Thu, 01/11/24 - 08:55 pm

Intuitive Surgical CEO: No Comment on New Multiport Robot

Medical Devices and Diagnostics Industry

Thu, 01/11/24 - 08:50 pm

Intuitive Surgical

robotic surgery

‘Let The Good Times Roll Again’: VCs Confident in Biotech Activity for ’24

BioSpace

Thu, 01/11/24 - 11:38 am

venture capital

JPM24: Even after Seagen buyout, Pfizer oncology chief still eyes ADC deals

Fierce Pharma

Thu, 01/11/24 - 11:34 am

antibody-drug conjugate

JPM24: ‘Diabesity’ duopoly between Novo, Lilly takes center stage

Medical Marketing and Media

Thu, 01/11/24 - 11:18 am

JPM 24: How Takeda beat 'almost every biopharmaceutical company' to win Nimbus’ TYK2 med

Fierce Biotech

Thu, 01/11/24 - 11:17 am

Nimbus Therapeutics

Amgen has potential to compete with established leaders in obesity drugs

Biopharma Reporter

Thu, 01/11/24 - 11:13 am

JPM24: In booming obesity field, Novo Nordisk is 'just getting going,' CEO says

Fierce Pharma

Wed, 01/10/24 - 06:27 pm

Lars Fruergaard Jorgensen

JPM24, Day 3: Gene editors take the stage to talk business development, germline edits

Fierce Biotech

Wed, 01/10/24 - 11:56 am

JPM24: BioMarin's new CEO Hardy says top priority is expansion of dwarfism drug Voxzogo

Fierce Pharma

Wed, 01/10/24 - 11:43 am

Alexander Hardy

JPM2024: Big Tech Poised to Disrupt Biopharma with AI-Based Drug Discovery

BioSpace

Wed, 01/10/24 - 09:55 am

artificial intelligence

JPM24: After 'clearing the decks,' Alkermes ready to roll as pure-play neuroscience company

Fierce Pharma

Wed, 01/10/24 - 09:44 am

JPM 2024: Renewal is a common theme among pharma CEOs

Medical Marketing and Media

Tue, 01/9/24 - 10:06 pm

Novo CEO expects patients to stay on Wegovy longer than older weight loss drugs

Reuters

Tue, 01/9/24 - 09:59 pm

Lars Fruergaard Jorgensen

JPM24: Amgen CEO hopes to take a bite of competitive obesity market with unique approach

Fierce Pharma

Tue, 01/9/24 - 10:54 am

JPM24: Bristol Myers Squibb CEO Boerner emphasizes organic pipeline over recent M&A deals

Fierce Pharma

Tue, 01/9/24 - 10:49 am

Bristol Myers Squibb

Christopher Boerner

Pages